Edition:
United Kingdom

Procter & Gamble Co (PG.N)

PG.N on New York Stock Exchange

75.84USD
9:01pm BST
Change (% chg)

$-1.54 (-1.99%)
Prev Close
$77.38
Open
$76.89
Day's High
$77.10
Day's Low
$75.40
Volume
2,524,909
Avg. Vol
3,010,632
52-wk High
$94.67
52-wk Low
$70.74

Latest Key Developments (Source: Significant Developments)

Procter & Gamble Announces Pricing Of Debt Tender Offer
Wednesday, 23 May 2018 

May 23 (Reuters) - Procter & Gamble Co ::PROCTER & GAMBLE ANNOUNCES PRICING OF ITS DEBT TENDER OFFER.P&G - MAXIMUM AGGREGATE PURCHASE PRICE THAT P&G WILL PAY IN TENDER OFFER IS ABOUT $1.404 BILLION.P&G - SETTLEMENT DATE FOR SECURITIES TENDERED AT/PRIOR TO EARLY TENDER DEADLINE & ACCEPTED FOR PURCHASE IS EXPECTED TO BE MAY 25, 2018.  Full Article

Procter & Gamble Announces $1.25 Billion Debt Tender Offer
Wednesday, 9 May 2018 

May 9 (Reuters) - Procter & Gamble Co ::PROCTER & GAMBLE ANNOUNCES $1.25 BILLION DEBT TENDER OFFER.P&G - TENDER OFFER WILL EXPIRE AT MIDNIGHT, NEW YORK CITY TIME, AT END OF JUNE 6, 2018.  Full Article

Teva And P&G Have Agreed To Terminate The PGT Healthcare Partnership
Thursday, 19 Apr 2018 

April 19 (Reuters) - Procter & Gamble Co ::TEVA AND THE PROCTER & GAMBLE COMPANY HAVE AGREED TO TERMINATE THE PGT HEALTHCARE PARTNERSHIP.TEVA PHARMACEUTICAL INDUSTRIES LTD - NO SIGNIFICANT (MATERIAL) NET FINANCIAL TRANSFER BETWEEN TEVA AND P&G WILL RESULT FROM DISSOLUTION.TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS PLANNED TO TAKE EFFECT JULY 1, 2018 SUBJECT TO RECEIPT OF APPLICABLE REGULATORY APPROVALS.TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS NOT EXPECTED TO HAVE A MATERIAL EFFECT (IMPACT) ON TEVA'S 2018 FINANCIAL OUTLOOK.TEVA PHARMACEUTICAL INDUSTRIES LTD - IN 2017, COMBINED SALES FROM TEVA'S PGT OTC PRODUCTS AND TEVA NON-PGT OTC PRODUCTS WERE APPROXIMATELY $1 BILLION.TEVA PHARMACEUTICAL - WILL MERGE ITS OTC INTERESTS RETURNING FROM PGT WITH A PORTFOLIO OF OTC ASSETS ACQUIRED IN 2016 VIA ACTAVIS ACQUISITION.  Full Article

P&G Acquires the Consumer Health Business Of Merck KGaA, Darmstadt, Germany
Thursday, 19 Apr 2018 

April 19 (Reuters) - Procter & Gamble Co ::ACQUIRES THE CONSUMER HEALTH BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY.SAYS ANNOUNCED IT HAS SIGNED AN AGREEMENT TO ACQUIRE CONSUMER HEALTH BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY.HAS SIGNED AGREEMENT TO ACQUIRE CONSUMER HEALTH BUSINESS OF MERCK KGAA, FOR PURCHASE PRICE OF ABOUT 3.4 BILLION EURO.  Full Article

P&G Nears Deal To Acquire Merck KGaA's Consumer-Health Unit - WSJ
Thursday, 19 Apr 2018 

April 18 (Reuters) - :P&G NEARS DEAL TO ACQUIRE MERCK KGAA’S CONSUMER-HEALTH UNIT - WSJ, CITING SOURCES.  Full Article

P&G Declares Dividend Increase
Tuesday, 10 Apr 2018 

April 10 (Reuters) - Procter & Gamble Co ::P&G DECLARES DIVIDEND INCREASE.BOARD DECLARED INCREASED QTRLY DIVIDEND OF $0.7172/SHARE ON COMMON STOCK AND ON SERIES A AND SERIES B ESOP CONVERTIBLE CLASS A PREFERRED STOCK.INCREASED QUARTERLY DIVIDEND OF $0.7172/SHARE REPRESENTS A 4% INCREASE COMPARED TO PRIOR QUARTERLY DIVIDEND.  Full Article

P&G Announces Q2 Core Earnings Per Share $1.19
Tuesday, 23 Jan 2018 

Jan 23 (Reuters) - P&G ::ANNOUNCES SECOND QUARTER EARNINGS.Q2 CORE EARNINGS PER SHARE $1.19.Q2 EARNINGS PER SHARE $0.93 FROM CONTINUING OPERATIONS.Q2 SALES $17.4 BILLION VERSUS I/B/E/S VIEW $17.35 BILLION.Q2 EARNINGS PER SHARE VIEW $1.14 -- THOMSON REUTERS I/B/E/S.REMAIN ON TRACK TO ACHIEVE FISCAL YEAR OBJECTIVES.QTRLY ORGANIC SALES INCREASED TWO PERCENT.QTRLY GROOMING SEGMENT ORGANIC SALES DECREASED THREE PERCENT.QTRLY FABRIC AND HOME CARE SEGMENT ORGANIC SALES INCREASED THREE PERCENT.MAINTAINING ITS GUIDANCE FOR ORGANIC SALES GROWTH IN RANGE OF TWO TO THREE PERCENT FOR FISCAL 2018.QTRLY BABY, FEMININE AND FAMILY CARE SEGMENT ORGANIC SALES DECREASED ONE PERCENT.ESTIMATES ALL-IN SALES GROWTH OF ABOUT THREE PERCENT FOR FISCAL 2018.RAISING ITS 2018 CORE EARNINGS PER SHARE GROWTH OUTLOOK FROM FIVE TO SEVEN PERCENT TO FIVE TO EIGHT PERCENT.TRANSITIONAL IMPACTS DUE TO IMPACTS OF TAX REFORM RESULTED IN A PROVISIONAL NET CHARGE OF $628 MILLION FOR QUARTER ENDED DECEMBER 31, 2017.RAISING UPPER-END OF 2018 EPS GUIDANCE RANGE TO REFLECT POTENTIAL BENEFIT FROM TAX ACT.2018 GAAP EARNINGS PER SHARE ARE EXPECTED TO DECREASE 30% TO 32% VERSUS FISCAL YEAR 2017 GAAP EPS OF $5.59.FOR QUARTER ENDED DECEMBER 31, 2017 AND FISCAL 2018, TAX IMPACTS ARE RESULTING IN A NET BENEFIT OF ABOUT $135 MILLION.2018 GAAP EPS ESTIMATE INCLUDES ABOUT $0.10 PER SHARE OF NON-CORE RESTRUCTURING COSTS AND $0.24 PER SHARE OF NON-CORE CHARGES RELATED TO TAX ACT.  Full Article

P&G Declares Quarterly Dividend Of $0.6896 Per Share On Common Stock
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Procter & Gamble Co ::P&G DECLARES QUARTERLY DIVIDEND.P&G - DECLARED A QUARTERLY DIVIDEND OF $0.6896 PER SHARE ON COMMON STOCK.  Full Article

Amazon Been In Talks With Several Companies Including P&G, Clorox About Letting Them Promote Products On Its Echo Devices - CNBC‍​
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Amazon.Com Inc ::AMAZON HAS BEEN IN TALKS WITH SEVERAL COMPANIES INCLUDING P&G AND CLOROX ABOUT LETTING THEM PROMOTE PRODUCTS ON ITS ECHO DEVICES - CNBC, CITING SOURCES ‍​.  Full Article

Clorox, Clorox Parties, P&G Parties EnterS Into First Extension & Amendment Of Amended And Restated Jv Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Clorox Co ::CLOROX-ON DEC 19, CLOROX PARTIES, P&G PARTIES ENTERED INTO FIRST EXTENSION & AMENDMENT OF AMENDED AND RESTATED JV AGREEMENT, DATED AS OF JAN 31,2003.CLOROX CO SAYS PURSUANT TO TERMS OF EXTENSION, TERM OF JV AGREEMENT WILL EXPIRE ON JANUARY 31, 2026 - SEC FILING.  Full Article

EU mergers and takeovers (June 18)

BRUSSELS, June 18 The following are mergers under review by the European Commission and a brief guide to the EU merger process: